Skip to main content

Table 1 Baseline characteristics between the two groups

From: Safety profile of preoperative administration of low-molecular-weight heparin on minimally invasive lung cancer surgery: a randomized controlled trial

Characteristics

POL group (n = 111)

PRL group (n = 101)

p value

Age

55.88 ± 10.11

58.17 ± 9.99

0.100

Weight

58.12 ± 8.99

60.39 ± 9.03

0.068

Sex

 Female

70

64

0.964

 Male

41

37

Preoperative LMWH duration

0

3.98 ± 2.10

 

Surgery approach

 VATS

99

83

0.144

 RATS

12

18

Surgery technique

 Lobectomy

79

70

0.767

 Sublobar resection

32

31

TNM stage

 Stage I

106

97

1.0

 Stage II–IV

5

4

Postoperative LMWH duration

3.29 ± 2.66

3.23 ± 2.32

0.860

PT

11.19 ± .62

11.31 ± 0.74

0.170

APTT

28.19 ± 3.72

28.30 ± 3.19

0.815

TT

20.08 ± 1.32

19.65 ± 2.13

0.077

FIB

2.68 ± 0.72

2.74 ± 0.78

0.523

INR

0.95 ± 0.06

0.96 ± 0.07

0.233

PLT

182.81 ± 57.51

192.82 ± 61.90

0.224

HGB

133.50 ± 13.23

134.33 ± 13.07

0.646